Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
(NY:
GSK
)
50.99
+0.09 (+0.18%)
Official Closing Price
Updated: 7:00 PM EDT, May 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
45
46
Next >
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
↗
September 12, 2022
Via
Benzinga
September 2022 Stock Considerations
↗
September 08, 2022
Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago.
Via
Talk Markets
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
↗
September 07, 2022
Via
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
↗
September 06, 2022
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
↗
September 02, 2022
Via
Benzinga
GSK's Rare Blood Cancer Candidate Goes Under FDA Review
↗
August 17, 2022
Via
Benzinga
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
↗
August 17, 2022
Via
Benzinga
Why IDEAYA Biosciences Shares Plunging Today
↗
August 15, 2022
Via
Benzinga
GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report
↗
August 10, 2022
Via
Benzinga
Novartis Appoints Merck Executive As Research Head
↗
September 01, 2022
Via
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
↗
August 30, 2022
Via
Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
↗
August 29, 2022
Via
Benzinga
Is Sanofi A Buy, Despite Recent Stumbles?
August 19, 2022
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Via
MarketBeat
Topics
Intellectual Property
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
↗
August 18, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
Recent Stock Purchase August 2022
↗
August 18, 2022
I just continue to have a long-term outlook, continue to invest, diversify my portfolio even more and just hold on.
Via
Talk Markets
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug
↗
August 17, 2022
Shares extended deep losses following a Zantac-inspired downturn last week.
Via
Investor's Business Daily
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
↗
August 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
August 15, 2022
On Monday, 31 companies hit new 52-week lows.
Via
Benzinga
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
August 15, 2022
From
The Schall Law Firm
Via
Business Wire
Landmark Drug Pricing Reform Bill Passes Congress House
↗
August 15, 2022
The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...
Via
Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
↗
August 12, 2022
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
August 12, 2022
From
The Schall Law Firm
Via
Business Wire
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
↗
August 11, 2022
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 11, 2022
On Thursday, 22 companies reached new 52-week lows.
Via
Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
↗
August 11, 2022
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.
Via
InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
↗
August 11, 2022
These companies are at the center of lawsuits claiming Zantac causes cancer.
Via
Investor's Business Daily
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
August 11, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
↗
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
45
46
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today